spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Infinity 

 HSMN NewsFeed - 6 Feb 2026
Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Jan 2023
Infinity Neuro Receives CE Mark Approval for Their First Device to Treat Stroke
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 29 Nov 2022
Regulus Therapeutics Announces Appointments of Industry Veterans, Drs. Rekha Garg and Claire Padgett, to Lead Clinical Development, Regulatory and Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2022
Nuvalent Announces Leadership Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Mar 2022
Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jun 2021
Medtronic Gains FDA Clearance of UNiD(TM) Patient-Specific Rods for Use with CD Horizon(TM) Solera(TM) Voyager(TM) and Infinity(TM) OCT Spinal Systems
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 8 Mar 2021
Abbott Introduces NeuroSphere(TM) Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 22 Jan 2021
Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
Devices Neurology FDA
 HSMN NewsFeed - 3 Sep 2020
Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2020
Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
Devices Neurology FDA
 HSMN NewsFeed - 24 Jan 2020
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Devices Neurology FDA
 HSMN NewsFeed - 15 Jan 2020
China's HEDY Group Acquires 10 Elekta Cancer Treatment Systems
Devices Oncology
 HSMN NewsFeed - 22 Aug 2019
Erasca Announces Key Leadership Team Appointments and Recruits World-Class Research and Development Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 May 2019
FogPharma Strengthens New Modality Drug Hunting Team with Appointment of Howard Stern as Chief Scientific Officer and Peter Fekkes as Vice President of Discovery Bioscience
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2018
ArcherDX, Inc. Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 7 Aug 2018
Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Aug 2018
Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
Devices Neurology FDA
 HSMN NewsFeed - 25 Apr 2018
MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2018
Elekta Strengthens Presence in Mexico With Government Tender for Radiation Therapy Technology
Devices Oncology
 HSMN NewsFeed - 8 Mar 2018
Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Vision Announces Series of Product Milestones and Launches Across Portfolio at American Academy of Ophthalmology 2017 Meeting
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 16 May 2017
Introducing the Softest CPAP Mask from ResMed
Devices Product Launch
 HSMN NewsFeed - 1 Mar 2017
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
Devices Oncology Personnel
 HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Nov 2016
Gamida Cell Names Julian Adams, Ph.D. New Chairman of the Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Nov 2016
Verastem Licenses Duvelisib from Infinity Pharmaceuticals
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 13 Jul 2016
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 26 Apr 2016
MD Anderson Cancer Center to Acquire Elekta Linear Accelerators and Other Radiotherapy Solutions
Devices Oncology
 HSMN NewsFeed - 7 Dec 2015
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Nov 2015
Amethyst Radiotherapy Orders Elekta Cancer Treatment Solutions for European Expansion
Devices Oncology
 HSMN NewsFeed - 3 Nov 2015
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Sep 2015
Infinity Expands Pipeline with Addition of IPI-549, an Immuno-Oncology Development Candidate for the Treatment of Solid Tumors
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Apr 2015
Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2014
Wright Medical Group, Inc. Announces Commercial Launch of INFINITY(R) Total Ankle System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 7 May 2014
Elekta announces strategic partnership with the Centre hospitalier de l'Universite de Montreal
Devices Oncology
 HSMN NewsFeed - 2 Jul 2013
Warp Drive Bio Appoints Co-Founder Gregory Verdine, Ph.D., to Chief Executive Officer; Expands Team with Two Key Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2013
Elekta: Kuopio University Hospital First in Finland with Elekta’s New Beam Shaping Innovation for Radiotherapy of Cancer Patients
Devices Oncology
 HSMN NewsFeed - 7 Feb 2013
Banner MD Anderson Cancer Center Acquires Multiple Elekta Cancer Management Systems
Devices Oncology
 HSMN NewsFeed - 15 Oct 2012
Promedior Appoints Elizabeth Trehu, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2012
Danish Clinics Anticipate Benefits for Cancer Patients with Elekta’s Innovative Beam-shaping Solution for Radiotherapy
Devices Oncology
 HSMN NewsFeed - 29 Aug 2012
U.S. FDA Grants Priority Review of ZYTIGA(R) (abiraterone acetate) sNDA for Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Jul 2012
Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
Devices Oncology
 HSMN NewsFeed - 24 Jul 2012
Infinity Announces New Addition to Senior Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2012
United Kingdom's National Health Service Includes Masimo Pleth Variability Index(R) as "High Impact Innovation" for Intra Operative Fluid Management
Devices Monitoring Surgery
 HSMN NewsFeed - 24 May 2012
Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
Diagnostics FDA
 HSMN NewsFeed - 26 Apr 2012
Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
Devices Oncology
 HSMN NewsFeed - 11 Apr 2011
Infinity Announces Appointment of Joshua Hamermesh as Vice President, Business and Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2011
Catheter Connections Appoints Charity Williams as Chief Business Officer and In-House Counsel
Devices Personnel
 HSMN NewsFeed - 18 Jan 2011
SheerVision, Inc. Announces Expansion Plans
Devices Surgery
 HSMN NewsFeed - 10 Jan 2011
VisionCare Ophthalmic Technologies Closes $31 Million Series E Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2010
Infinity Augments Executive Leadership Team, Appointing New Chief Medical Officer and New Vice President, Product Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2010
Infinity Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Ltd. Exercise Rights to Develop and Commercialize Infinity's FAAH Pain Program Worldwide
Biopharmaceuticals
 HSMN NewsFeed - 25 Oct 2010
Major Medical Center in India is Country's First to Offer Fast Arc-based Radiation Therapy Technique for Patients With Cancer
Devices Oncology
 HSMN NewsFeed - 14 Oct 2010
Catabasis Pharmaceuticals Appoints Michael Curtis, Ph.D., as Vice President, Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2010
VisionCare Announces FDA Approval for First-Ever Implantable Telescope for End-Stage Macular Degeneration
Devices Ophthalmology FDA
 HSMN NewsFeed - 18 May 2010
Infinity Announces Senior Management Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2010
Stryker Enters Strategic Marketing Agreement With Intuitive Surgical
Devices Surgery
 HSMN NewsFeed - 26 Apr 2010
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Feb 2010
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 18 Feb 2010
Roseville Radiation Oncology Center (ROC) Redefines Efficiency With Elekta VMAT Radiotherapy Treatments
Devices Oncology
 HSMN NewsFeed - 7 Dec 2009
Infinity Names Adelene Q. Perkins Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2009
Elekta Demonstrates Continued Leadership in Image Guidance at 2009 ASTRO Annual Meeting
Devices Oncology
 HSMN NewsFeed - 19 Oct 2009
Aileron Therapeutics Appoints Steven Kafka, Ph.D. as Company's First Chief Financial Officer and Vice President, Finance and Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2009
Massachusetts General Hospital Selects Elekta as New Vendor for Complete Cancer Treatment Solution
Devices Oncology
 HSMN NewsFeed - 9 Sep 2009
Constellation Pharmaceuticals Appoints Renowned Cancer Biologist Edward E. Harlow, Jr., Ph.D. as Company's CSO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2009
Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Aug 2009
Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery
Devices Neurosurgery
 HSMN NewsFeed - 13 Aug 2009
Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 13 Aug 2009
Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 18 Jun 2009
Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System
Devices Oncology
 HSMN NewsFeed - 23 Apr 2009
Elekta Contract Provides MAGNET Cooperative Access to Leading Radiation Therapy Solutions
Devices Oncology Group Purchasing
 HSMN NewsFeed - 20 Jan 2009
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2008
Infinity Announces the Promotion of Adelene Q. Perkins to President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2008
Elekta Announces Availability of Elekta Infinity With VMAT Technology for Fast, More Precise Treatment of Cancer
Devices Oncology
 HSMN NewsFeed - 16 Sep 2008
Elekta Announces Availability of Elekta Infinity With VMAT Technology for Fast, More Precise Treatment of Cancer
Devices Oncology
 HSMN NewsFeed - 29 Apr 2008
Constellation Pharmaceuticals Closes $32 Million in Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Mar 2008
Sepracor Presents Safety Data on OMNARIS(TM)AQ and OMNARIS(TM) HFA Nasal Sprays at American Academy of Allergy Asthma and Immunology (AAAAI)
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2008
Draeger Launches New Infinity(R) Omega Solution in the USA - Featuring a Widescreen for Integrated Patient Monitoring and Electronic Records, Both at the Bedside
Devices Monitoring
 HSMN NewsFeed - 4 Feb 2008
Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Feb 2008
Thermage Introduces Infinity Program at AAD
Devices Dermatology
 HSMN NewsFeed - 29 Oct 2007
Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
Devices Oncology
 HSMN NewsFeed - 17 Sep 2007
Infinity and MedImmune Receive Orphan Drug Designation for IPI-504 for Treatment of Gastroinstestinal Stromal Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Jun 2007
AILERON Therapeutics Announces $7 Million in Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 May 2007
ProCertus BioPharm, Inc. Closes $2.3 Million Series A Financing Led by Venture Investors LLC
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 May 2007
Micrus Endovascular Launches Cashmere Microcoil System to Treat Complex Cerebral Aneurysms
Devices Neurology Interventional
 HSMN NewsFeed - 2 Apr 2007
Draeger Medical Introduces New WiFi-Based Infinity(R) TeleSmart Patient-Worn Telemetry System
Devices Monitoring FDA
 HSMN NewsFeed - 8 Feb 2007
Pfizer's Sutent Receives FDA Approval to Include New First-Line Advanced Kidney Cancer Data in Label
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Dec 2006
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2006
NeoGuide Systems Closes Series C Financing
Devices Venture Capital
 HSMN NewsFeed - 22 May 2006
Draeger Medical files 510(k) Pre-market Notification for New Patient-worn Monitoring System
Devices Monitoring FDA
Return to NewsFeed  

 Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 22 additional stories matching:
Infinity
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!